Literature DB >> 3661496

A novel whole blood capillary technic for measuring the prothrombin time.

F V Lucas1, A Duncan, R Jay, R Coleman, P Craft, B Chan, L Winfrey, D R Mungall, J Hirsh.   

Abstract

The prothrombin time (PT) is frequently performed to monitor anticoagulant therapy. Although relatively simple to perform, it requires venipuncture and laboratory resources for sample handling and analysis. A recently developed capillary whole blood device that uses fingerstick samples was evaluated. Paired capillary whole blood and reference plasma PTs were performed in 858 samples from 732 subjects. The PT for normal volunteers (n = 193) was 11.8 +/- 0.9 seconds with the use of the new instrument and 12.1 +/- 0.5 seconds with the use of the reference method. In samples from 539 patients receiving anticoagulants, the correlation coefficient between the two methods was 0.96. Venous whole blood without anticoagulant and capillary whole blood gave equivalent results, which suggests that the fingersticks do not effect the quality of the specimen. Variation in hematocrit between 23.4% (0.34) and 53.8% (0.538) did not alter the performance of the instrument. The new instrument is easy to use and may allow testing by nonlaboratory personnel and patients. It obviates the need for venipuncture, provides immediate results, and appears to be comparable in accuracy to current reference methods.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3661496     DOI: 10.1093/ajcp/88.4.442

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  12 in total

Review 1.  Out-of-hospital coagulation monitoring and management.

Authors:  J E Ansell
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

Review 2.  The role of point-of-care anticoagulation monitoring in arterial and venous thromboembolic disorders.

Authors:  C R Zimmerman
Journal:  J Thromb Thrombolysis       Date:  2000-04       Impact factor: 2.300

3.  Validity of CoaguChek S for home monitoring of anticoagulant therapy in pediatrics.

Authors:  James Hill; Sébastien Perreault; Michel Dorval
Journal:  Can J Cardiol       Date:  2007-01       Impact factor: 5.223

Review 4.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 5.  Oral anticoagulation control: the European perspective.

Authors:  David A Fitzmaurice
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

6.  Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulation.

Authors:  I Jennings; R J Luddington; T Baglin
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

Review 7.  Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation.

Authors:  A M van den Besselaar
Journal:  J Thromb Thrombolysis       Date:  2001-09       Impact factor: 2.300

8.  Reliability of international normalised ratios from two point of care test systems: comparison with conventional methods.

Authors:  Leon Poller; Michelle Keown; Nikhil Chauhan; Anton M H P van den Besselaar; Armando Tripodi; Caroline Shiach; Jorgen Jespersen
Journal:  BMJ       Date:  2003-07-05

Review 9.  Home monitoring of anticoagulation.

Authors:  Julie Hambleton
Journal:  J Thromb Thrombolysis       Date:  2003 Aug-Oct       Impact factor: 2.300

10.  Primary care anticoagulant management using near patient testing.

Authors:  M Daly; A W Murphy; C O'Hanlon; A Cosgrove; D McKeown; E Egan
Journal:  Ir J Med Sci       Date:  2003 Jan-Mar       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.